WO2010013423A1 - 皮膚外用剤及びシワ改善剤 - Google Patents
皮膚外用剤及びシワ改善剤 Download PDFInfo
- Publication number
- WO2010013423A1 WO2010013423A1 PCT/JP2009/003489 JP2009003489W WO2010013423A1 WO 2010013423 A1 WO2010013423 A1 WO 2010013423A1 JP 2009003489 W JP2009003489 W JP 2009003489W WO 2010013423 A1 WO2010013423 A1 WO 2010013423A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- skin
- alkylthioglycoside
- wrinkle
- lauryl
- external preparation
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Definitions
- the present invention relates to a skin external preparation and a wrinkle improving agent.
- Non-patent Document 1 the histological change of the skin with aging is greatly different between the exposed part and the non-exposed part, and is distinguished into photoaging and physiological aging.
- the exposed part is always exposed to strong oxidative stress such as ultraviolet rays, the progress of aging is remarkable.
- photoaged skin for example, thickening of the epidermis is observed, and deep and large wrinkles are produced, which is unfavorable for cosmetic purposes.
- Non-patent Document 1 the moisture state of the stratum corneum is highly correlated with the occurrence of small wrinkles (Non-patent Document 1), and the stratum corneum increases in thickness while the epidermis becomes thin ( Non-patent documents 1, 2) are pointed out.
- Non-Patent Document 3 a wrinkle improving substance having high safety and sufficient effect is desired.
- alkylthioglycosides are used as micellar surfactants, for example, in oral medicines such as oral agents for treating diabetes (Patent Document 1), or as membrane protein solubilizers (Patent Documents 2 and 3).
- Patent Document 1 it is known that n-octyl- ⁇ -D-thio-glucopyranoside can be used as a percutaneous absorption enhancer for drugs (Patent Document 4). No investigation has been made on the action.
- JP 2002-69000 A JP 61-7288 A Japanese Patent Laid-Open No. 5-32689 JP 63-218630 A
- An object of the present invention is to provide a skin external preparation and a wrinkle improving agent that are excellent in the effect of improving wrinkles that are noticeably manifested in aging due to aging, and that are excellent in the effect of keeping cosmetically healthy skin. is there.
- the present inventor has improved skin wrinkles, particularly wrinkles that appear prominently in exposed areas, and keeps the skin healthy cosmetically by external application to the skin. It was confirmed that the effects and safety were excellent, and the present invention was completed.
- this invention provides the skin external preparation containing the alkylthioglycoside represented by General formula (1).
- G-SR 1 (1) (In the formula, G represents a sugar, R 1 represents an alkyl group having 10 to 18 carbon atoms, and the bond between G and the SR 1 group is a ⁇ -glycoside bond.)
- this invention provides the wrinkle improving agent by the photoaging containing the alkylthioglycoside represented by General formula (2).
- G-SR 2 (2) (In the formula, G represents a sugar, R 2 represents an alkyl group having 8 to 18 carbon atoms, and the bond between G and SR 2 is a ⁇ -glycoside bond.)
- this invention provides use of the alkylthioglycoside (2) represented by General formula (2) for manufacture of the wrinkle improving agent by photoaging.
- G-SR 2 (2) (In the formula, G represents a sugar, R 2 represents an alkyl group having 8 to 18 carbon atoms, and the bond between G and SR 2 is a ⁇ -glycoside bond.) Furthermore, the present invention provides a method for improving wrinkles due to photoaging of the skin, characterized by applying the alkylthioglycoside represented by the general formula (2) to the skin.
- G-SR 2 (2) (In the formula, G represents a sugar, R 2 represents an alkyl group having 8 to 18 carbon atoms, and the bond between G and SR 2 is a ⁇ -glycoside bond.)
- the present invention can provide a skin external preparation and a wrinkle improving agent that are excellent in improving wrinkles that occur particularly in exposed areas with aging, and that keep the skin in a dermatological and cosmetically healthy state.
- the alkylthioglycoside used in the present invention is represented by the general formula (1) or (2), and examples of the sugar residue represented by G include monosaccharides, disaccharides, and oligosaccharides. Glucose, galactose, lactose, maltose and the like are preferable, and glucose or galactose is particularly preferable.
- the alkyl chain represented by R 1 which is an aglycon moiety may have 10 to 18 carbon atoms, and preferably has 10 to 12 carbon atoms.
- the alkyl chain represented by R 2 can be one having 8 to 18 carbon atoms, preferably one having 8 to 12 carbon atoms.
- the alkyl chain may be linear or branched, and saturated or unsaturated, but is preferably saturated linear.
- alkylthioglycosides include C 8 -C 12 alkylthioglucosides and C 8 -C 12 alkylthiogalactosides. Specifically, octylthioglucoside, decylthioglucoside, laurylthioglucoside, octylthiogalactoside, decylthiogalactoside, and laurylthiogalactoside are more preferable.
- lauryl thioglucoside represented by the following formula (3) lauryl thiogalactoside represented by the formula (4) and octylthioglucoside represented by the formula (5) are particularly preferable.
- the alkyl group represented by R 2 in the general formula (2) has 8 to 18 carbon atoms.
- the alkyl group represented by R 1 in the general formula (1) has 10 to 18 carbon atoms.
- Examples of the synthesis method of the alkylthioglycoside represented by the general formula (1) or (2) include the following methods.
- the synthesis method of the structural formula (4) commercially available 1,2,3,4,6-penta-O-acetyl-D-galactopyranose is used as a starting material in a chloroform solvent. It can be produced by reacting with dodecanethiol and boron trifluoride etherate (BF 3 .OEt 2 ) and then subjecting to deacetylation treatment.
- alkylthioglycosides can be purchased and used.
- decyl 1-thio- ⁇ -D-glucopyranoside octyl 1-thio- ⁇ -D-glucopyroxide (manufactured by SIGMA-ALDRICH) and the like can be used.
- the alkylthioglycoside represented by the general formula (1) or (2) suppresses the progression of wrinkles on the skin, particularly wrinkles caused by photoaging, as shown in the test examples and examples described later. And has the effect of improving the symptoms of wrinkles. Therefore, if a composition containing an alkylthioglycoside is applied to the skin, wrinkles can be improved.
- a composition containing an alkylthioglycoside is useful as a skin external preparation for improving wrinkles.
- the content of the alkylthioglycoside (1) or (2) in the external preparation for skin or wrinkle improving agent of the present invention is 0.001 to 10% by mass (hereinafter simply referred to as%) based on the total amount of the external preparation for skin or wrinkle improving agent. Are preferred). More preferably, it is 0.01 to 5%. Within this range, a sufficient wrinkle improvement effect can be obtained.
- the form of the external preparation for skin or wrinkle improving agent of the present invention may be any form that can be applied to the skin, and examples thereof include forms such as solutions, emulsions, creams, lotions, gels, packs, and bath preparations.
- the external preparation for skin and wrinkle improving agent of the present invention include pigments, fragrances, preservatives, surfactants, pigments, antioxidants, whitening agents, moisturizers, ultraviolet absorbers, and ultraviolet scattering.
- An agent, an oily component, a thickener, alcohols, organic acids, a pH adjuster, water, and the like can be appropriately blended within the scope of achieving the object of the present invention.
- Moisturizing Test Example 2 The moisture reduction rate of lauryl thiogalactoside (the compound of Production Example 2) was calculated by the following test method, and the moisturizing property was evaluated.
- FIG. 1 shows that lauryl thiogalactoside does not suppress moisture volatilization in a dry state and does not have sufficient moisturizing action.
- Wrinkle improvement test example The wrinkle improvement effect when the sample containing the base alone or laurylthiogalactoside (the compound of Production Example 2) was applied to photoaged skin was examined by the following test method.
- the size and depth of the wrinkle are comprehensively evaluated with the naked eye, 3 indicating that “a large and deep wrinkle can be confirmed”, 2 indicating “a wrinkle can be confirmed”, 1 indicating “a wrinkle cannot be confirmed”, and “normal” “The texture is observed” was scored on a scale of 0 to 4.
- the skin thickness was measured by collecting the skin of all layers and preparing a skin slice sample according to a standard method, then staining with hematoxylin and eosin, and measuring the thickness of the epidermis with image analysis software (Microanalyzer, manufactured by Pola Digital Japan). .
- Example 2 Sample and Experimental Method A sample was prepared by blending 1% lauryl thiogalactoside with a 50 vol% ethanol aqueous solution (base) (Example 1). A sample containing only the base was used as Comparative Example 1. First, 0.1 mL of these samples were applied to the back skin (about 2.5 cm in diameter) of hairless mice at a frequency of once a day and five times a week from the fifth week after the start of UV irradiation to the fourth week after the end of irradiation. Until applied. And after completion
- Example 1 showed a significantly lower wrinkle score value compared to Comparative Example 1, and it was found that lauryl thiogalactoside was effective against wrinkles induced by photoaging.
- the wrinkle improving agent containing lauryl thiogalactoside of Example 1 clearly has an effect of improving wrinkles due to photoaging, which is moisturizing lauryl thiogalactoside. It can be seen that it is not due to action.
- Example 2 skin creams having the following compositions were prepared according to the preparation method described later, and the wrinkle improvement effect was evaluated by the following operations using the skin cream as a sample.
- Example 2 The skin cream of Example 2 or Comparative Example 2 was applied to 5 healthy persons (women, 43-56 years old) who listed wrinkles in the corners of the eyes as a skin problem in a preliminary questionnaire.
- a questionnaire survey was conducted on the condition of wrinkles. Decide each sample to the left or right, wrinkles in the corners of the eye corners twice a day for 2 months (60 days) after face washing in the morning and after bathing in the evening (about each corner about each corner) 4 cm 2 , 2 ⁇ 2 cm), about 0.2 mL each.
- Preparation Method C component lauryl thioglucoside was added to B component, and A and B components were each heated and dissolved at 80 ° C, then mixed and stirred, and cooled to 30 ° C to prepare each skin cream. .
- Example 3 A skin lotion with the following composition was prepared in accordance with a conventional method, and a questionnaire survey was conducted by 20 healthy people (women, 43-56 years old) who listed wrinkles in the corner of their eyes as a skin problem in a preliminary questionnaire. It was.
- the skin lotion of Example 3 has a large number of people who feel that wrinkles are less noticeable than before use, and the factor is that the size of wrinkles is reduced rather than the number of wrinkles It can be seen that wrinkles due to photoaging were improved. In addition, skin abnormalities such as irritation and itching due to the skin lotion of the present invention were not observed.
- Examples 4 and 5 milky lotion
- the emulsion of the present invention was prepared according to a conventional method with the following composition.
- Examples 6 and 7 (Day Essence) The day essence of the present invention was prepared according to a conventional method with the following composition.
- Examples 8 and 9 The sunscreen of the present invention was prepared according to a conventional method with the following composition.
- fragrances having the following fragrance formulations were used.
- Applicable to pharmaceuticals, quasi-drugs, cosmetics, etc. as a skin external preparation and wrinkle improving agent.
- lotions, emulsions, creams, packs, bathing agents, etc. It is very useful in terms of skin beauty.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
G-SR1 (1)
(式中、Gは糖を示し、R1は炭素数10~18のアルキル基を示し、GとSR1基との結合は、β-グリコシド結合である。)
G-SR2 (2)
(式中、Gは糖を示し、R2は炭素数8~18のアルキル基を示し、GとSR2基との結合は、β-グリコシド結合である。)
また、本発明は、一般式(2)で表されるアルキルチオグリコシド(2)の、光老化によるシワの改善剤製造のための使用を提供するものである。
G-SR2 (2)
(式中、Gは糖を示し、R2は炭素数8~18のアルキル基を示し、GとSR2基との結合は、β-グリコシド結合である。)
さらに、本発明は、一般式(2)で表されるアルキルチオグリコシドを皮膚に適用することを特徴とする皮膚の光老化によるシワの改善方法を提供するものである。
G-SR2 (2)
(式中、Gは糖を示し、R2は炭素数8~18のアルキル基を示し、GとSR2基との結合は、β-グリコシド結合である。)
また、アルキル鎖は直鎖及び分岐鎖、並びに飽和及び不飽和のいずれのものも用いることができるが、飽和直鎖状であることが好ましい。
例えば、上記構造式(4)の合成方法であれば、市販されている1,2,3,4,6-ペンタ-O-アセチル-D-ガラクトピラノースを出発原料とし、クロロホルム溶媒中で、1-ドデカンチオール、及び三フッ化ホウ素エーテラート(BF3・OEt2)と反応させた後、脱アセチル化処理を施すことにより製造することができる。
1,2,3,4,6-ペンタ-O-アセチル-D-グルコピラノース(1g)をクロロホルム(10mL)に溶解した溶液に、1-ドデカンチオール(0.57g)とBF3・OEt2(1.6mL)を加え、攪拌した。反応終了後、反応液を炭酸水素ナトリウム水溶液で洗浄後、クロロホルム層を無水硫酸マグネシウムで乾燥、次いで減圧下溶媒を留去した。得られた残渣をメタノール溶媒中、ナトトリウムメチラートを用いて、脱アセチル化反応に供し、目的とするラウリルチオグルコシド(0.68g、トータル収率72%)を得た。
1,2,3,4,6-ペンタ-O-アセチル-β-D-ガラクトピラノース(1g)をクロロホルム(10mL)に溶解した溶液に、1-ドデカンチオール(0.57g)とBF3・OEt2(1.6mL)を加え、攪拌した。反応終了後、反応液を炭酸水素ナトリウム水溶液で洗浄後、クロロホルム層を無水硫酸マグネシウムで乾燥、次いで減圧下溶媒を留去した。得られた残渣をメタノール溶媒中、ナトリウムメチラートを用いて、脱アセチル化反応に供し、目的とするラウリルチオガラクトシド(0.56g、トータル収率60%)を得た。
次の試験方法によりラウリルチオガラクトシド(製造例2の化合物)の水分減少率を算出し、保湿性を評価した。
イオン交換水にてラウリルチオガラクトシド濃度が10質量%となるように調整した試料を、樹脂製の容器に0.5g測りとり初期重量(W0)を測定した。
次に、試料をシリカゲルデシケーター(RT;25℃、RH;20%)に静置し、経時における試料重量(Wt)を測定した。
試験終了後、試料を乾燥機(50℃)で2時間乾燥させた後に、シリカゲルデシケーター内に2時間静置し乾燥重量(Ws)を測定した。
対照試料として水のみを用いたものを同様の操作を行い、下記式により水分減少率を算出した。結果を図1に示す。
(2)算出式
・水分減少率(%)=Ht/H0×100
(Ht=Wt-Ws,H0=W0-Ws)
基剤のみ、又はラウリルチオガラクトシド(製造例2の化合物)を配合した試料を、光老化させた皮膚に適用したときのシワ改善効果を次の試験方法により調べた。
試験開始時10週齢のヘアレスマウス1群10匹を用いた。
(2)-1.光老化条件及び測定方法
光老化は、UVAとUVBを1日1回、週5回、8週間照射することで誘発させた。照射量はUVAが20J/cm2、25J/cm2、30J/cm2、UVBを20mJ/cm2、30mJ/cm2、40mJ/cm2と一週ごとに増量し、3週目以降は最大量を照射した。
シワ改善効果はシワスコアと表皮厚により評価した。シワスコアは、Bissettらの方法(Photochem.Photobiol.46:367-378、1987)に従って採点した。すなわち、シワの大きさ及び深さを肉眼で総合的に評価し、「大きく深いシワが確認できる」を3、「シワが確認できる」を2、「シワが確認できない」を1、「正常なキメが観察される」を0の4段階で採点した。表皮厚の測定は、全層皮膚を採取して定法に従って皮膚切片標本を作製したのちヘマトキシリン・エオシン染色を施し、表皮の厚さを画像解析ソフト(マイクロアナライザー、日本ポラデジタル社製)で測定した。
50vol%エタノール水溶液(基剤)に、ラウリルチオガラクトシドを1%配合した試料を調製した(実施例1)。また基剤のみの試料を比較例1とした。まず、これらの試料0.1mLをヘアレスマウスの背部皮膚(直径約2.5cm)に1日1回、一週間に5回の頻度で、UV照射開始後5週目から照射終了後4週目まで塗布した。そして、塗布終了後にシワスコアを採点し、屠殺後、皮膚を採取した。シワスコアと表皮厚はともに基剤塗布群を対照として比較した。結果を表1及び表2に示す。
本実施例及び比較例では、下記組成のスキンクリームを後述の調製法にしたがって調製し、それを試料として次の操作によってシワ改善効果を評価した。
C成分のラウリルチオグルコシドをB成分に添加して、A,B成分を各々80℃に加熱溶解した後、混合して撹拌しつつ、30℃まで冷却して各スキンクリ-ムを調製した。
下記組成のスキンローションを常法にしたがって調製し、事前アンケートで目尻のシワを肌悩みとして挙げた20名の健常人(女性、43~56歳)に1ヶ月間使用してもらいアンケート調査を行った。
下記組成により本発明の乳液を常法に従って調製した。
下記組成により本発明のデイエッセンスを常法に従って調製した。
下記組成により本発明のサンスクリーンを常法に従って調製した。
Claims (12)
- 一般式(1)で表されるアルキルチオグリコシドを含有する皮膚外用剤。
G-SR (1)
(式中、Gは糖を示し、R1は炭素数10~18のアルキル基を示し、GとSR1基との結合は、β-グリコシド結合である。) - アルキルチオグリコシドが、C10-C12アルキルチオグルコシド又はC10-C12アルキルチオガラクトシドである請求項1記載の皮膚外用剤。
- アルキルチオグリコシドが、ラウリルチオグルコシド又はラウリルチオガラクトシドである請求項1記載の皮膚外用剤。
- 一般式(2)で表されるアルキルチオグリコシドを含有する光老化によるシワの改善剤。
G-SR2 (2)
(式中、Gは糖を示し、R2は炭素数8~18のアルキル基を示し、GとSR2基との結合は、β-グリコシド結合である。) - アルキルチオグリコシドが、C8-C12アルキルチオグルコシド又はC8-C12アルキルチオガラクトシドである請求項4記載のシワ改善剤。
- アルキルチオグリコシドが、ラウリルチオグルコシド、ラウリルチオガラクトシド又はオクチルチオグルコシドである請求項4記載のシワ改善剤。
- 一般式(2)で表されるアルキルチオグリコシドの、光老化によるシワの改善剤製造のための使用。
G-SR2 (2)
(式中、Gは糖を示し、R2は炭素数8~18のアルキル基を示し、GとSR2基との結合は、β-グリコシド結合である。) - アルキルチオグリコシドが、C8-C12アルキルチオグルコシド又はC8-C12アルキルチオガラクトシドである請求項7記載の使用。
- アルキルチオグリコシドが、ラウリルチオグルコシド、ラウリルチオガラクトシド又はオクチルチオグルコシドである請求項7記載の使用。
- 一般式(2)で表されるアルキルチオグリコシドを皮膚に適用することを特徴とする皮膚の光老化によるシワの改善方法。
G-SR2 (2)
(式中、Gは糖を示し、R2は炭素数8~18のアルキル基を示し、GとSR2基との結合は、β-グリコシド結合である。) - アルキルチオグリコシドが、C8-C12アルキルチオグルコシド又はC8-C12アルキルチオガラクトシドである請求項10記載の方法。
- アルキルチオグリコシドが、ラウリルチオグルコシド、ラウリルチオガラクトシド又はオクチルチオグルコシドである請求項10記載の方法。
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200980130006.8A CN102112103B (zh) | 2008-07-28 | 2009-07-24 | 烷基硫代糖苷在对光老化所产生的皱纹的改善剂的制造中的用途及改善方法 |
EP09802672.7A EP2314277B1 (en) | 2008-07-28 | 2009-07-24 | External preparation for skin, and wrinkle-repairing agent |
JP2010522607A JP5555161B2 (ja) | 2008-07-28 | 2009-07-24 | 皮膚外用剤及びシワ改善剤 |
US13/055,651 US20110124586A1 (en) | 2008-07-28 | 2009-07-24 | External preparation for skin, and wrinkle-repairing agent |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008-194068 | 2008-07-28 | ||
JP2008194068 | 2008-07-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2010013423A1 true WO2010013423A1 (ja) | 2010-02-04 |
Family
ID=41610138
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2009/003489 WO2010013423A1 (ja) | 2008-07-28 | 2009-07-24 | 皮膚外用剤及びシワ改善剤 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20110124586A1 (ja) |
EP (1) | EP2314277B1 (ja) |
JP (1) | JP5555161B2 (ja) |
KR (1) | KR101269400B1 (ja) |
CN (1) | CN102112103B (ja) |
TW (1) | TWI392516B (ja) |
WO (1) | WO2010013423A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106632534A (zh) * | 2016-09-29 | 2017-05-10 | 广州市汇吉科技企业孵化器有限公司 | 一种辣木内硫代葡萄糖苷的提取工艺及其应用 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS617288A (ja) | 1984-06-20 | 1986-01-13 | Doujin Kagaku Kenkyusho:Kk | アルキルチオグルコシド誘導体 |
JPS63218630A (ja) | 1987-03-06 | 1988-09-12 | Sekisui Chem Co Ltd | 経皮吸収促進剤 |
JPH04273818A (ja) * | 1991-02-28 | 1992-09-30 | Kissei Pharmaceut Co Ltd | 経皮投与製剤 |
JPH0532689A (ja) | 1991-08-01 | 1993-02-09 | Nippon Fine Chem Co Ltd | 膜タンパク質の可溶化剤 |
JPH06219947A (ja) * | 1993-01-26 | 1994-08-09 | Kinki Univ | 経皮投与製剤 |
JP2002069000A (ja) | 2000-08-28 | 2002-03-08 | Kimigafuchi Gakuen | 糖尿病治療用経口剤 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
DE19911053B4 (de) * | 1999-03-12 | 2004-10-28 | Biotec Asa | Kosmetische und/oder pharmazeutische Zubereitungen |
JP4273818B2 (ja) * | 2003-04-14 | 2009-06-03 | ダイキン工業株式会社 | 調湿装置 |
US20060275229A1 (en) * | 2005-05-17 | 2006-12-07 | Sreekumar Pillai | Skin care active complex and methods of using same |
FR2903004B1 (fr) * | 2006-07-03 | 2009-07-10 | Oreal | Utilisation en cosmetique d'un derive c-glycoside en association avec de l'acide ascorbique |
-
2009
- 2009-07-24 KR KR1020107028968A patent/KR101269400B1/ko active IP Right Grant
- 2009-07-24 WO PCT/JP2009/003489 patent/WO2010013423A1/ja active Application Filing
- 2009-07-24 EP EP09802672.7A patent/EP2314277B1/en active Active
- 2009-07-24 US US13/055,651 patent/US20110124586A1/en not_active Abandoned
- 2009-07-24 JP JP2010522607A patent/JP5555161B2/ja active Active
- 2009-07-24 CN CN200980130006.8A patent/CN102112103B/zh active Active
- 2009-07-28 TW TW098125316A patent/TWI392516B/zh not_active IP Right Cessation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS617288A (ja) | 1984-06-20 | 1986-01-13 | Doujin Kagaku Kenkyusho:Kk | アルキルチオグルコシド誘導体 |
JPS63218630A (ja) | 1987-03-06 | 1988-09-12 | Sekisui Chem Co Ltd | 経皮吸収促進剤 |
JPH04273818A (ja) * | 1991-02-28 | 1992-09-30 | Kissei Pharmaceut Co Ltd | 経皮投与製剤 |
JPH0532689A (ja) | 1991-08-01 | 1993-02-09 | Nippon Fine Chem Co Ltd | 膜タンパク質の可溶化剤 |
JPH06219947A (ja) * | 1993-01-26 | 1994-08-09 | Kinki Univ | 経皮投与製剤 |
JP2002069000A (ja) | 2000-08-28 | 2002-03-08 | Kimigafuchi Gakuen | 糖尿病治療用経口剤 |
Non-Patent Citations (5)
Title |
---|
BISSETT ET AL., PHOTOCHEM. PHOTOBIOL., vol. 46, 1987, pages 367 - 378 |
KIICHIRO DANNO: "Fragrance Journal", vol. 26, 15 April 1998, FRAGRANCE JOURNAL LTD., article "Photoaging and wrinkles", pages: 11 - 17 |
See also references of EP2314277A4 |
SETSUKO JITSUKAWA; KAZUSHIGE HARA: "Fragrance Journal", vol. 34, 15 October 2006, FRAGRANCE JOURNAL LTD., article "A new xylose-derived active cosmetic ingredient for anti-aging - Toward sustainable development", pages: 35 - 39 |
YOSHIO HAMADA; GEN FUKUSE: "Fragrance Journal", vol. 26, 15 April 1998, FRAGRANCE JOURNAL LTD., article "Retinoids as anti-wrinkle treatment", pages: 75 - 77 |
Also Published As
Publication number | Publication date |
---|---|
JPWO2010013423A1 (ja) | 2012-01-05 |
JP5555161B2 (ja) | 2014-07-23 |
KR20110040775A (ko) | 2011-04-20 |
CN102112103A (zh) | 2011-06-29 |
US20110124586A1 (en) | 2011-05-26 |
KR101269400B1 (ko) | 2013-05-29 |
TW201010736A (en) | 2010-03-16 |
TWI392516B (zh) | 2013-04-11 |
CN102112103B (zh) | 2013-06-26 |
EP2314277B1 (en) | 2017-04-19 |
EP2314277A4 (en) | 2015-06-03 |
EP2314277A1 (en) | 2011-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4584991B2 (ja) | 皮膚化粧料及びシワ改善剤 | |
DE60027455T2 (de) | Oligosaccharidealdonsäure und ihre topische verabreichung | |
TW201532621A (zh) | 抗氧化劑組成物及其使用方法 | |
CN111265420A (zh) | 一种高效保湿舒敏修护组合物及其应用 | |
JP4567732B2 (ja) | 皮膚化粧料及びシワ改善剤 | |
WO2017100873A1 (pt) | Composição cosmética e seu uso | |
JP2572730B2 (ja) | 皮膚化粧料 | |
JP3753188B2 (ja) | 新規のサリチル酸誘導体及び化粧品用/又は皮膚用組成物におけるその用途 | |
JP5555161B2 (ja) | 皮膚外用剤及びシワ改善剤 | |
JP4579564B2 (ja) | シワ改善剤 | |
JP4934280B2 (ja) | シワ改善剤 | |
JP2002516836A (ja) | 皮膚の繊維芽細胞の代謝の刺激剤としてのジアセチル化ラクトンを含むソホロリピドの使用法 | |
JP4488933B2 (ja) | シワ改善剤及び皮膚外用組成物 | |
WO2012117340A1 (en) | Method for the cosmetic treatment of skin redness | |
JP4456918B2 (ja) | シワ改善剤 | |
JP5244284B2 (ja) | シワ改善剤 | |
JP4359197B2 (ja) | シワ改善剤及び皮膚化粧料 | |
JP3826132B2 (ja) | シワ改善剤 | |
JP2005220043A (ja) | シワ改善剤 | |
JP4971635B2 (ja) | シワ改善剤 | |
JP5768114B2 (ja) | エージング対応用の皮膚外用剤の製造方法 | |
JP2013129615A5 (ja) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200980130006.8 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09802672 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010522607 Country of ref document: JP |
|
ENP | Entry into the national phase |
Ref document number: 20107028968 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13055651 Country of ref document: US |
|
REEP | Request for entry into the european phase |
Ref document number: 2009802672 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009802672 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |